![]() |
| Irritable Bowel Syndrome |
|
Free Subscription
1 Aliment Pharmacol Ther |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Irritable Bowel Syndrome is free of charge.
Prevalence of Opioid Use and Associated Healthcare Outcomes in Rome IV Irritable
Bowel Syndrome in the United Kingdom.
Aliment Pharmacol Ther. 2025 Oct 8. doi: 10.1111/apt.70400.
PubMed
Abstract available
Melatonin alleviates diarrhea and visceral hypersensitivity in rats with
diarrhea-predominant irritable bowel syndrome by modulating of the
TLR4/MyD88/NF-kappaB pathway.
BMC Gastroenterol. 2025;25:715.
PubMed
Pre-packaged food targeted to gastrointestinal pathologies: are they low in
FODMAP?
Br J Nutr. 2025 Oct 9:1-16. doi: 10.1017/S000711452510528.
PubMed
Abstract available
Cell Mol Biol (Noisy-le-grand)
Bitter frankincense water modulates hepatic enzyme activity in female patients
with irritable bowel syndrome.
Cell Mol Biol (Noisy-le-grand). 2025;71:80-85.
PubMed
Abstract available
Cell Mol Gastroenterol Hepatol
Sympathetic Overactivation Drives Colonic Eosinophil Infiltration Linked to
Visceral Hypersensitivity in Irritable Bowel Syndrome.
Cell Mol Gastroenterol Hepatol. 2025 Oct 7:101658.
PubMed
Abstract available
Efficacy of encapsulated fecal microbiota transplantation and FMT via rectal
enema for irritable bowel syndrome: a double-blind, randomized,
placebo-controlled trial (CAP-ENEMA FMT Trial).
Front Med (Lausanne). 2025;12:1648944.
PubMed
Abstract available
Elevated levels of TRAb IgG autoantibodies are not recognized in endometriosis by
the current clinical methods.
Front Med (Lausanne). 2025;12:1612079.
PubMed
Abstract available
Impaired glucose metabolism in irritable bowel syndrome: personalised
low-glycaemic diet as potential therapeutic target.
Gut. 2025 Oct 5:gutjnl-2025-336797. doi: 10.1136/gutjnl-2025-336797.
PubMed
Cold-inducible RNA-binding protein promotes gut barrier dysfunction and visceral
hypersensitivity via activating mast cells in IBS-D.
Int Immunopharmacol. 2025;166:115640.
PubMed
Abstract available
Post-cholecystectomy bile acid diarrhea in a teenager with sickle cell disease:
Case report.
Int J Surg Case Rep. 2025;136:112018.
PubMed
Abstract available
Ergosterol Regulates Visceral Hypersensitivity and Intestinal Motility in
Irritable Bowel Syndrome Through Microbiota-Metabolites-AhR Signaling Axis.
J Agric Food Chem. 2025 Oct 8. doi: 10.1021/acs.jafc.5c11549.
PubMed
Abstract available
Comment on "Associations of Long-Term Night Shift Work With Incident Irritable
Bowel Syndrome: A Population-Based Cohort Study".
J Gastroenterol Hepatol. 2025 Oct 7. doi: 10.1111/jgh.70113.
PubMed
Prevalence of temporomandibular disorder in irritable bowel syndrome (IBS)
patients: a systematic review.
J Oral Facial Pain Headache. 2025;39:66-74.
PubMed
Abstract available
Somatic symptom disorder in patients with irritable bowel syndrome or ulcerative
colitis - Cross-sectional baseline findings from the SOMA.GUT-RCT.
J Psychosom Res. 2025;198:112395.
PubMed
Abstract available
Gut microbiota dysbiosis and metabolic perturbations of bile/glyceric acids in
major depressive disorder with IBS comorbidity.
mBio. 2025 Oct 7:e0244725. doi: 10.1128/mbio.02447.
PubMed
Abstract available
Role of Anti-Vinculin Quantitative ELISA Test in Diagnosing Irritable Bowel
Syndrome and Inflammatory Bowel Disease.
Med Arch. 2025;79:287-291.
PubMed
Abstract available
Smartphone Application With Health Coaching Facilitates Multi-Symptom Improvement
in IBS Patients: A Pilot Feasibility Trial.
Neurogastroenterol Motil. 2025 Oct 7:e70179. doi: 10.1111/nmo.70179.
PubMed
Abstract available
Relationships Among Gut Microbiota, Plasma Inflammatory Cytokines, and Irritable
Bowel Syndrome: A Mediation Mendelian Randomization Study.
Neurogastroenterol Motil. 2025 Oct 9:e70178. doi: 10.1111/nmo.70178.
PubMed
Abstract available
Dietary index for gut microbiota and risk of incident irritable bowel syndrome: a
large-scale prospective cohort study.
Nutr J. 2025;24:157.
PubMed
Abstract available
Microbiota and short chain fatty acid relationships underlie clinical
heterogeneity and identify key microbial targets in irritable bowel syndrome
(IBS).
Sci Rep. 2025;15:35375.
PubMed
Abstract available
Thank you for your interest in scientific medicine.